Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

which is a competitor to Illumina technology, like its mid-range NextSeq 2000 sequencer, and the forthcoming launch of Aviti24 that combines sequencing and cell characteristic mapping in a single ...

Q4 2024 Management View CEO Bob Ragusa highlighted 2024 as a transformative year for the company, noting the separation from Illumina and the launch of public trading in June. He mentioned that U.S.

In this article, we will take a detailed look at the Top 10 AI Stocks Buzzing on Latest News.

China has launched an anti-trust probe against Google, following Trump’s 10% tariffs on imports. Though Google’s search ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Genomic sequencing remains a relatively early stage market, and expanding sequencing indications, including the nascent liquid biopsy applications that would use its sequencers, create large growth ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session ...